Assignee
MITOIMMUNE THERAPEUTICS INC
KR·0 granted patents·9 pending applications·0 citations·filing 2021–2024
Top patents by PatentIndex Score
9 records- 0163US2025213583A1Antiviral pharmaceutical composition and use thereofMITOIMMUNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0263US2025082646A1Ovarian anti-aging pharmaceutical composition and use thereofMITOIMMUNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0359US2024374646A1Composition for inhibiting inflammation or aging of stem cells, and method for inhibiting inflammation or aging by using sameMITOIMMUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0458US2024269145A1Use of indole compound as inhibitors of ferroptosisMITOIMMUNE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0555US2025289785A1Indole derivative, method for preparing same, and use thereofMITOIMMUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0655US2025122155A1Novel indole derivative, pharmaceutical composition comprising same, and use thereofMITOIMMUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0753US2024199598A1Sulfate of 5-[(1,1-dioxido-4-thiomorpholinyl)methyl]-2-phenyl-n-(tetrahydro-2h-pyran-4-yl)-1h-indole-7-amine, and novel crystal form thereofMITOIMMUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0853US2024043409A1Crystalline forms of 5-[(1,1-dioxido-4-thiomorpholinyl)methyl]-2-phenyl-n-(tetrahydro-2h-pyran-4-yl)-1h-indol-7-amineMITOIMMUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0950US2024009202A1Mitochondria-targeted antioxidant as agent for treating pathologic inflammation caused by mabc-r infectionMITOIMMUNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →